Clinical Trials
9 trialsNCT03938324 2025-07-28
PiCASO
Duke University
Phase NA Completed
NCT01804166 2025-02-04
A Research Study to Bank Samples for Future Evaluation to Identify Biomarkers That Predispose Crohn's Disease and Ulcerative Colitis Patients to Develop Hepatosplenic T-Cell Lymphoma (HSTCL)
Janssen Scientific Affairs, LLC
Phase 4 Completed
NCT01714726 2021-05-26
Evaluation of Efficacy and Safety of MEDI2070 in Patients With Active, Moderate-to-severe Crohn's Disease.
AstraZeneca
Phase 2 Completed
NCT02574637 2021-05-26
Evaluation of Efficacy and Safety of Brazikumab (MEDI2070) in Participants With Active, Moderate to Severe Crohn's Disease
AstraZeneca
Phase 2 Terminated
NCT03723447 2021-02-17
TINGLE
Cedars-Sinai Medical Center
Phase 4 Completed
NCT01369329 2016-12-07
A Study to Evaluate the Safety and Efficacy of Ustekinumab in Patients With Moderately to Severely Active Crohn's Disease Who Have Failed or Are Intolerant to Tumor Necrosis Factor (TNF) Antagonist Therapy (UNITI-1)
Janssen Research & Development, LLC
Phase 3 Completed
NCT00325078 2015-12-29
Infliximab to Treat Crohn'S-like Inflammatory Bowel Disease in Chronic Granulomatous Disease
National Institutes of Health Clinical Center (CC)
Phase 1/2 Terminated
NCT01056913 2014-01-29
NITI CAR27 (ColonRing) Compression Anastomosis in Colorectal Surgery
St John of God Hospital, Vienna
Phase 4 Completed
NCT01034358 2012-10-23
Immune Response to the Human Papillomavirus Vaccine in Young Women With Inflammatory Bowel Disease
Mayo Clinic
Phase 4 Completed